Gait, cOgnitiOn & Decline (GOOD)
- Conditions
- Mild DementiaHealthyModerate DementiaMild Cognitive Impairment
- Registration Number
- NCT02350270
- Lead Sponsor
- University Hospital, Angers
- Brief Summary
The main objective of the GOOD initiative was to determine which spatio-temporal gait parameters and/or combination(s) of spatio-temporal gait parameters best differentiate between cognitively healthy individuals (CHI), patients with mild cognitive impairment (MCI) and those with mild and moderate dementia.
- Detailed Description
Gait disorders are frequent in individuals with cognitive disorders. However, the profile of spatio-temporal gait parameters in the different cognitive status in aging (from normal cognition to dementia) has been poorly studied. Determining this profile associated with the severity of cognitive disorders may be helpful to understand the complex interplay between gait and cognitive disorders and, thus, may have important implication for the diagnosis process of patients with and without dementia. For instance, defining a motor phenotype of the severity of cognitive disorders by using quantitative gait measurements could be used to improve the prediction and the diagnosis of dementia.
The investigators hypothesized that, compared to CHI, people with MCI and mild dementia could be characterized by specific phenotypes of spatio-temporal gait parameters measured with the GAITRite® system, and that these profiles could be explained by declines in domain-specific cognitive performance.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2800
- Being 60 years old and older
- Ability to answer questions
- Opposition to the use of information collected for research purposes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Spatio-temporal gait parameters This outcome is assessed at inclusion Spatio-temporal gait parameters were measured at steady state walking using GAITRite®-system.
- Secondary Outcome Measures
Name Time Method Clinical assessment This outcome is assessed at inclusion This outcome was assessed by a questionnaire.
Cognitive status This outcome is assessed at inclusion Cognitive status was assessed by cognitive testing.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hospital
🇫🇷Angers, France
University Hospital🇫🇷Angers, FranceOlivier Beauchet, MD, PhDPrincipal Investigator